Chemical Structure : MK-2206 dihydrochloride
CAS No.: 1032350-13-2
货号: PC-42551Not For Human Use, Lab Use Only.
MK-2206 dihydrochloride is a potent, orally active allosteric Akt inhibitor with IC50 of 5/12 nM for Akt1/Akt2 respectively.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥880 | In stock | |
| 25 mg | ¥1480 | In stock | |
| 50 mg | ¥2480 | In stock | |
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MK-2206 dihydrochloride is a potent, orally active allosteric Akt inhibitor with IC50 of 5/12 nM for Akt1/Akt2 respectively.
MK-2206 shows 5-fold less potent against human Akt3 (IC50=65 nM).
MK-2206 synergistically inhibits cell proliferation of human cancer cell lines in combination with erlotinib or lapatinib in vitro.
MK-2206 suppresses the Akt phosphorylation that is induced by carboplatin and gemcitabine.
| 分子量 | 480.389 | |
| 分子式 | C25H23Cl2N5O | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
DMSO |
|
| Chemical Name/SMILES |
1,2,4-Triazolo[3,4-f][1,6]naphthyridin-3(2H)-one, 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-, hydrochloride (1:2) |
|
1. Hirai H, et al. Mol Cancer Ther. 2010 Jul;9(7):1956-67.
2. Cheng Y, et al. Mol Cancer Ther. 2012 Jan;11(1):154-64.
3. Whicker ME, et al. BMC Cancer. 2016 Jul 27;16:550.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright